Thus, withanolide E may prove to be a powerful reagent for assessing the relative importance of cFLIP levels for TRAIL resistance in cancer cells, as well as providing a means of overcoming cFLIP-associated TRAIL resistance. Here, CFLAR is linked to cancer.